Fragrance compositions and use thereof for improving sleep
Fragrance compositions comprising one or more fragrance compounds for use in increasing the duration of sleep and/or improving quality of sleep in a subject is disclosed. Fragrance compositions comprising one or more fragrance compounds for use in increasing the quality of sleep in a subject (i.e., an increase in the time the subject is asleep during the night, a decrease in the time the subject is awake during the night, an increase in the time the subject experiences REM sleep, an increase in the time the subject experiences deep sleep, an increase in the time the subject experiences light sleep; and an increase in overall sleep efficiency) is disclosed. The composition can be incorporated into various consumer end products.
1. A method of improving at least one sleep parameter of a subject, wherein the method comprises:
providing a fragrance accord; and
administering the fragrance accord to the subject in an amount effective to improve the at least one sleep parameter;
wherein the fragrance accord comprises:
i) beta-ionone in an amount of from about 15% to about 30% by weight,
ii) at least one floral compound in an amount of from about 10% to about 60% by weight, and
iii) one musk compound, wherein the musk compound is selected from the group consisting of (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a, 7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran, 5-cyclohexadecen-1-one, L-muscone, (12E)-1-oxacyclohexadec-12-en-2-one, and 1,4-dioxacycloheptadecane-5,17-dione; and
wherein the at least one sleep parameter is selected from the group consisting of a decrease in number of total minutes awake, an increase in total minutes asleep, an increase in sleep efficiency, an increase in the number of REM sleep minutes, an increase in the number of light sleep minutes, and an increase in the number of deep sleep minutes.
2. The method of claim 1 , wherein the floral compound is selected from the group consisting of myrcenol, ionone alpha, linalool, linalyl acetate, cyclamen aldehyde, dihydromyrcenol, lilial, geraniol, gamma-methyl ionone, nerol, phenylethyl alcohol, and methyl 3-oxo-2-pentylcyclopentaneacetate.
3. The method of claim 1 , wherein the musk compound is selected from the group consisting of (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a, 7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran, 5-cyclohexadecen-1-one, L-muscone, and 1,4-dioxacycloheptadecane-5,17-dione; and
wherein the floral compound is selected from the group consisting of myrcenol, ionone alpha, linalool, linalyl acetate, cyclamen aldehyde, dihydromyrcenol, lilial, geraniol, gamma-methyl ionone, nerol, phenylethyl alcohol, and methyl 3-oxo-2-pentylcyclopentaneacetate.
4. The method of claim 1 , wherein the fragrance accord further comprises one or more citrus, spicy, mentholic, fruity, woody, aldehydic, herbal, balsamic, or gourmand compounds.
5. The method of claim 2 , wherein the floral compound is selected from the group consisting of linalool, methyl 3-oxo-2-pentylcyclopentaneacetate, cyclamen aldehyde, geraniol, and phenylethyl alcohol.
6. The method of claim 1 , wherein the musk compound is selected from the group consisting of 5-cyclohexadecen-1-one, and 1,4-dioxacycloheptadecane-5,17-dione.
7. The method of claim 3 , wherein the floral compound is selected from the group consisting of linalool, methyl 3-oxo-2-pentylcyclopentaneacetate, cyclamen aldehyde, geraniol, and phenylethyl alcohol; and
wherein the musk compound is selected from the group consisting of 5-cyclohexadecen-1-one and 1,4-dioxacycloheptadecane-5,17-dione.
8. A consumer product comprising a fragrance accord, wherein the fragrance accord comprises:
i) beta-ionone in an amount of from about 15% to about 30% by weight,
ii) at least one floral compound in an amount of from about 10% to about 60% by weight, and
iii) one musk compound, wherein the musk compound is selected from the group consisting of (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran, 5-cyclohexadecen-1-one, L-muscone, (12E)-1-oxacyclohexadec-12-en-2-one, and 1,4-dioxacycloheptadecane-5,17-dione.
9. The consumer product of claim 8 , wherein the fragrance accord is provided at least in part by a fragrance delivery system,
wherein said fragrance delivery system is selected from the group consisting of a Polymer Assisted Delivery (PAD) system, a Molecule-Assisted Delivery (MAD) system, a Cyclodextrin (CD) system, a Starch Encapsulated Accord (SEA) system, and a Zeolite & Inorganic Carrier (ZIC) system.